Glaukos Corp.
Joseph E Gilliam (PRESIDENT & COO) sells GKOS shares
About this filing
Glaukos Corp. (GKOS) filed Form 4 (insider transaction) with the SEC on Nov 18, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Joseph E Gilliam · PRESIDENT & COO
Rule 10b5-1 plan · adopted Aug 13, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +82 | $69.30 | $5,682.60 | 71,684 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +100 | $48.46 | $4,846.00 | 71,784 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +200 | $55.18 | $11,036.00 | 71,984 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +279 | $55.18 | $15,395.22 | 72,263 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +200 | $48.46 | $9,692.00 | 72,463 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F2, F1 | −861 | $250.00 | $215,250.00 | 71,602 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F3, F4 | −82 | $0.00 | $0.00 | 743 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F3, F4 | −100 | $0.00 | $0.00 | 19,151 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F3, F5 | −200 | $0.00 | $0.00 | 19,051 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F3, F6, F7 | −200 | $0.00 | $0.00 | 21,668 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F3, F8 | −279 | $0.00 | $0.00 | 35,004 | Direct |
Footnotes
- F1 Includes 40,039 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026.
- F3 The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026.
- F4 These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
- F5 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
- F6 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
- F7 Amount reported has been adjusted to reflect a mathematical error contained in the Form 4 filed with the SEC on November 16, 2026.
- F8 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
More GKOS filings
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 19, 2026
- 144
Filed Nov 18, 2026
- 144
Filed Nov 18, 2026
- 4
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.